Beyond ADMET: AI for medicines safety stakeholder survey
Imported from official source
The MHRA and the Regulatory Innovation Office (RIO) invite organisations to share their views on the use of artificial intelligence (AI) in medicines development.
This version
- Version
- 1 of 1
- Recorded
- September 16, 2026 10:30
- Change
- Initial
- Content hash
6a392e89aac5fff58225c1da2f054d93- All versions
- Revision history